Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Expert Opinion on Investigational Drugs|December 23, 2016
Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugsMark A Mastrodicasa, Christopher A Droege, Aaron M Mulhall, et al.
American Journal of Therapeutics|August 13, 2021
Clinical Experience, Characteristics, and Performance of an Acetaminophen Absorption Test in Critically Ill PatientsMolly E Droege, Abigail G Rhoades, Christopher A Droege, et al.
Respiratory Care|November 24, 2021
Assessment of Detectable Serum Tobramycin Concentrations in Patients Receiving Inhaled Tobramycin for Ventilator-Associated PneumoniaChristopher A Droege, Neil E Ernst, Madeline J Foertsch, et al.
The Journal of Surgical Research|January 29, 2020
Retrospective Evaluation of Venous Thromboembolism Prophylaxis in Elderly, High-Risk Trauma PatientsErica N Krantz, Carolyn D Philpott, Molly E Droege, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2021
Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement TherapyMohammad H Al-Shaer, Carolyn D Philpott, Christopher A Droege, et al.
The Journal of Trauma and Acute Care Surgery|January 25, 2014
Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patientsMolly E Droege, Eric W Mueller, Kelly M Besl, et al.
Pharmacotherapy|September 25, 2019
Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label StudyCarolyn D Philpott, Christopher A Droege, Molly E Droege, et al.
Pageof 2